Selective activity of dasatinib for the most common KIT mutation in melanoma (L576P)
Woodman SE
•
Trent JC
•
Stemke Hale K
more
Davies MA
2009
Journal
JOURNAL OF CLINICAL ONCOLOGY
WOS
SourceArchive
Rights
metadata only access
Subjects